Blow-Fill-Seal
5 billion doses / year, from 0.25 to 10 mL
CDMO: manufacturing technologies & formulation
From small-batch production to large volumes, we produce medicines and medical devices to match your needs to perfection.
Leveraging a wide range of technologies, we offer sterile and non-sterile liquid forms, for all volume requirements.
Preservative-free multi-doses
30 million / year, from 5 to 15 mL
Multi-doses with preservatives
70 million / year, from 1.5 to 15 mL
Liquid Stick Pack
600 million single doses / year, from 1 to 15 mL
Sprays
15 million / year, from 5 to 30 mL
Vials
40 million / year, from 10 to 500 mL
BFS for injectables
1 billion doses / year, from 0.25 à 2.7 mL
Others
Small multi-form batches, clinical batches, and orphan diseases
Added value for your products
✓
A fully integrated CDMO partner, located on four continents.
✓
Production sites regularly inspected and certified by major international health authorities (EMA, FDA, ANVISA, Health Canada, GFDA, etc.).
✓
Recognized expertise in the critical stages of scale-up and industrial transfer.
✓
High standards of traceability, regulatory compliance, and adaptability to each client's specific needs.
✓
A high level of traceability, regulatory compliance, and operational flexibility.
Manufacturing expertise
Transfert technologique et scale up
Scale-up & technology transfer
From laboratory research to industrial production, each transfer stage is carefully structured to ensure fluidity, performance, and compliance.
- Optimization of transitions to industrialization.
- Management of process transfers from your own sites or other CDMOs.
- In-depth technical validation ensuring robustness and reliability
Stick-pack
Industrial production
Thanks to our eight high-capacity industrial sites, we ensure robust and high-quality production for each batch.
- High-volume production to meet the needs of international markets
- Multi-format and multi-site capacities on several continents
- Operational reliability, cost optimization, and guaranteed supply continuity
pédiatrie
Flexible manufacturing capacities for small series and orphan drugs
- Dedicated infrastructures allow the production of small commercial batches, suitable for rare diseases and specific uses.
- Expertise in orphan drugs, ATUs (Temporary Authorizations for Use), and pediatric treatments.
- Support for phased launches and limited series.
- Manufacturing of hospital and niche products, meeting the specific needs of patients and prescribers.
Why trust us?
With a global presence and solidly recognized expertise, we are a reliable partner at every stage of your projects.
Our flexibility allows us to handle batches and formats of all sizes, while ensuring impeccable quality and compliance daily.
Committed to a responsible and sustainable approach, we integrate a concrete CSR vision directly within our industrial sites, to combine performance, innovation, and responsibility.
Innovation with a concrete CSR vision integrated into our industrial sites.
Quality commitments and regulatory compliance
Manufacturing in line with standards
GMP, FDA, EMA, ISO 13485
Comprehensive quality control
analytics, stability, batch release
Release and documentation
in line with ICH standards and international regulatory requirements
Do you have any questions? - See our FAQ on CDMO pharmaceutical manufacturing
Are your sites certified?
Our sites are certified according to local and international requirements, including EMA cGMP, US FDA, ANVISA (Brazil) guidelines, ISO 13485, ISO 9001 standards, and other regulatory standards applicable to the markets concerned.
Do you do small batches and large production runs?
Yes. We are able to handle both small volumes (orphan drugs, ATUs, etc.) and very large-scale industrial production.
What liquid pharmaceutical forms does Unither develop and manufacture (BFS single dose, multi-dose, sprays, solutions, gels, etc.)?
We produce sterile and non-sterile liquid medicines and medical devices, as well as single-dose products, sprays, stick-packs, vials, and tablets.